Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Belumosudil for Long-Standing Refractory Chronic Graft-Versus-Host Disease: A Two-Patient Case Report.

Clinical case reports·2026
Same author

Phase II study of lenalidomide maintenance after rituximab-methotrexatebased induction therapy in primary central nervous system lymphoma.

Haematologica·2026
Same author

Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01).

Blood·2026
Same author

Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cells.

Cancer immunology, immunotherapy : CII·2026
Same author

Aerosolized Pentamidine Is an Effective Prophylaxis for <i>Pneumocystis jiroveci</i> Pneumonia in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation.

Journal of Korean medical science·2026
Same author

A novel anti-CD20, concabody, enhances immunotherapy efficacy by targeting MPZL1 and augmenting antibody-induced cell death.

Frontiers in oncology·2026

相关实验视频

Updated: Jun 29, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K

在多发性髓瘤中探索细胞免疫疗法平台.

Manh-Cuong Vo1,2,3, Sung-Hoon Jung2,4, Van-Tan Nguyen2

  • 1Institute of Research and Development, Duy Tan University, Danang, Viet Nam.

Heliyon
|March 25, 2024
PubMed
概括
此摘要是机器生成的。

细胞免疫疗法在多发性骨髓瘤 (MM) 中表现有前途. 髓透淋巴细胞 (MILs) 和CAR T细胞提供了针对癌细胞的新途径,可能提高治疗效率并降低MM患者的毒性.

关键词:
细胞免疫疗法细胞免疫疗法树突细胞的树突细胞.透到骨髓的淋巴细胞多发性骨髓瘤是一种多发性骨髓瘤.自然杀手细胞是什么?

更多相关视频

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.1K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

相关实验视频

Last Updated: Jun 29, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K
Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

13.1K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

科学领域:

  • 血液学 血液学 血液学
  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.

背景情况:

  • 多发性骨髓瘤 (MM) 仍然是一个重大挑战,大多数患者经历了疾病复发,尽管治疗进展.
  • 新的治疗策略对于改善MM患者的治疗结果至关重要.

研究的目的:

  • 审查针对MM的细胞免疫疗法的最新创新.
  • 突出透髓淋巴细胞 (MIL) 和其他细胞工具在治疗MM的潜力.

主要方法:

  • 对MM的细胞免疫疗法的当前文献的综述.
  • 检查包括CAR T细胞,MILs,NK细胞和树突细胞在内的新方法.

主要成果:

  • 细胞免疫疗法,特别是CAR T细胞,正在成为MM的有效治疗方法.
  • MILs代表了采用疗法T细胞的有希望的来源,证明了强大的和特定的瘤细胞向.

结论:

  • 细胞免疫疗法的创新,包括MILs和CAR T细胞,为提高MM治疗的疗效和减少毒性提供了显著的希望.
  • 对这些细胞工具的进一步研究是有必要的,以优化MM治疗.